BBK Worldwide makes clinical engagement process easier with mobile apps
- Details
- Category: Development
BBK Worldwide, a leading clinical trial marketing firm, has unveiled two new mobile apps for patient and site engagement, My Clinical Study Buddy℠ and My Clinical Study Buddy℠ Protocol Pointers Edition. Available for Apple® and Android™ mobile phones and tablets, both apps are available on the App Store℠ and Google Play™ and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.
Scientists closing in on new obesity drug
- Details
- Category: Research
Obesity and diabetes are among the fastest growing health problems in the world, and the hunt is in for a pill that can fight the problem. Now a Danish/British team has come up with a smart tool that will speed up the scientific hunting process, and we may be one step closer to a pill against obesity.
Viral infections could be inhibited by naturally occurring protein
- Details
- Category: Research
By boosting a protein that naturally exists in our cells, an international team of researchers led by the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, has found a potential way to enhance our ability to sense and inhibit viral infections.
Researchers uncover common heart drug's link to diabetes
- Details
- Category: Research
McMaster University researchers may have found a novel way to suppress the devastating side effect of statins, one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease. The research team - led by Jonathan Schertzer, assistant professor of Biochemistry and Biomedical Sciences and Canadian Diabetes Association Scholar - discovered one of the pathways that link statins to diabetes.
Resistance to lung cancer targeted therapy can be reversed, study suggests
- Details
- Category: Research
Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth - a puzzling clinical setback that researchers have long tried to solve. Now, scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why that intrinsic resistance occurs - and they pinpoint a drug they say could potentially reverse it.
'Tomato pill' improves function of blood vessels in patients with cardiovascular disease
- Details
- Category: Research
A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the University of Cambridge. The incidence of cardiovascular disease varies worldwide, but is notably reduced in southern Europe, where a 'Mediterranean diet' consisting of a larger consumption of fruit, vegetables and olive oil predominates.
Design of self-assembling protein nanomachines starts to click
- Details
- Category: Research
A route for constructing protein nanomachines engineered for specific applications may be closer to reality. Biological systems produce an incredible array of self-assembling, functional protein tools. Some examples of these nanoscale protein materials are scaffolds to anchor cellular activities, molecular motors to drive physiological events, and capsules for delivering viruses into host cells.
More Pharma News ...
- International committee re-defines how multiple sclerosis is described and understood
- Anti-diabetic drug slows aging and lengthens lifespan
- 'Quadrapeutics' works in preclinical study of hard-to-treat tumors
- Understanding and overcoming a novel type of anticancer drug resistance
- FDA approves many drugs that predictably increase heart and stroke risk
- New way to treat HER2-positive breast cancer
- Scientists discover potential new target for cancer immunotherapy